When Ma issued a Paper Food and Drug Administration notice to Henry Medical (600276.SH) its anti-cancer products in the cancer under the concept of a red frame when the tragic; a 38-million bribery case, let Franc Group (000513.SZ) subsidiary Shanghai market in 2 years and completely
Hengrui Medicine, 2010, the most competitive listed companies in the domestic pharmaceutical first priority; Franc Group, the market competitiveness ranking fourth; Hong Chi Pharmaceutical domestic market share of the first children's medicine. In medicine
Livzon more harm than good
frequent accidents in which the three major pharmaceutical companies, Franc group might be called the In July 2010 the original owners Ren Chenyue Clinical Laboratory Center of Shanghai bribery cases, Franc Franc, a subsidiary of Group Reagent Co., Ltd. (hereinafter referred to Franc agent), together with two pharmaceutical companies together local Shanghai bribery 380,000 yuan, So for 2 years but the Shanghai market lost huge profits.
Chen Yue various hospitals in Shanghai quality supervision and inspection functions, so you can purchase through the hospital staff responsible for greeting people receiving services for bribery.
discipline in the Shanghai Health Bureau announced in the Commission, informed the two cases together, the Shanghai local pharmaceutical companies 134,000 yuan in bribe money, not Speaking Livzon. But projections down, a subsidiary bribery payments Livzon up 20.6 million. But the bribery money 206,000 yuan, the Shanghai Municipal Health Bureau has also led to the first time
2 16, the Shanghai Health Bureau informed that within two years of medical and health institutions at all levels in Shanghai in any name, form of acquisition of the three Franc Ltd. and other reagents production, operation of medicines , medical equipment and medical supplies. Shanghai Medical Device Organization within two years shall not accept the tender, including three companies, including Zhuhai Franc Equipments bidding to participate in bidding for procurement.
Earlier in the Essential Drugs List has blacklisted the relevant provisions after the accident did not enter the market within two years. The Shanghai Health Bureau, the disposal of so harshly, but also to play a warning. Times weekly on the edge of morning, told reporters.
Henry Two days after the outbreak of this event,
into a
immediately, January 28, 2011 the State Drug Administration of a paper document, so Henry medicine Finland's pharmaceutical preparations of oxygen in the heart of serious side effects, and overdose can be fatal, the State Food and Drug Administration decided to contain the right drug propoxyphene gradual withdrawal of the market.
same time, the Food and Drug Administration announced with the right medicine propoxyphene list of companies, including Henry Medical, Pharmaceutical Sinopharm subsidiary of Glory and East Pharmaceutical Group, Shenyang First Pharmaceutical Factory - which MEDICA Group has a few years ago to stop drug production and thus will not be announced. The Henry's involving pharmaceutical products, for the anti-cancer drug,
2 18, Henry announced on medicine, In this regard, while the morning of Die Zeit, told reporters, Pharmaceutical quality of a certain impact.
in Shanghai for the first time in the event of members were expelled from punishment, and a subsidiary of the event in Shanghai's business volume is not large, so the overall impact on the company is not large. total sales of such drugs as not high, so basically the company's normal profits would not have an impact. Current operating income accounted for reagents Franc 5.45%, representing the company in 2010 of the third quarter total revenue of 0.43%.
then press access times weekly earnings of both companies, found that bribery case involving the main diagnostic reagents Franc reagents and equipment, operating income in 2010 95.053 million yuan, accounting for Bi Dali Pearl Group's total revenue of 7.19%, and showed the trend of rising.
Livzon Group 2009 annual report, company in East China 513 million annual sales revenue of up to million. The protagonist Franc reagents bribery case in 2009 net profit of 32 million yuan, ranking the fifth subsidiary Franc. As the major markets in the world pharmaceutical market, the Shanghai market Franc reagents that
According to public information display, Dunning drugs are narcotic analgesic drugs, Henry had previously occupied 5.4% of the total Group sales amounted to 22.37 million yuan. Meanwhile, according to the State Food and Drug Administration Web site information, the name of Henry there is a medicine called naphthalene sulfonate propoxyphene the right to produce APIs.
addition, with the main Huashenjituan anticancer drug 5 days in 2011 rose 61.09 percent of the amazing singing all the way, the cancer had a stream and to replace the concept of super bacteria, hot money will be a new medical board hot round of speculation.
addition to position approach
as a According to the company secretaries, said the company had produced drugs involved, but it has nothing to do with the company, so no announcement. And the 32 days.
However, since the matter is out, cover up is not possible, not as a reasonable explanation is given time to remove all doubts. Notice the timely release clarification is necessary, it is to establish a trust system, but also reflects the ability of corporate public relations crisis.
who continue to dirty tricks scandal?
22 as
2010 年 11 months, Johnson & Johnson in Beijing hosted the nimesulide treatment of children in the last 6 years in thousands of cases of adverse reactions occur, and even several deaths. Johnson also was once the official website disabled
news release, the major pharmacies have shelves to nimesulide, a Hong Chi shares tumbled after the February 9 years after the opening bell, shares of Hong Chi all the way down, leading to February 14 emergency suspension, followed by 15 after the opening share price falling. Hong Chi, chairman of Hong Jianggong Pharmaceutical then open position, Then, the parties have to present their point of view, the State Food and Drug Administration on Feb. 18 news release, Many industry experts have also said that
angrily when the Hong Chi Johnson Pharmaceutical mischief, the current market, news has been, Kang Chi Pharmaceutical will jointly Baiyun Mountain and other domestic listed companies in seven major pharmaceutical against Johnson. Safety in the nimesulide has not been determined, the pharmaceutical market was bustling.
In his view, the current domestic market competition more fierce, winning a rival sub-formal and informal ways, the new drug market regulation will be implemented in March, the current Food and Drug Administration related to leadership said that after the implementation of new norms, the Chinese may die 500 pharmaceutical companies, pharmaceutical stocks for the whole, this is a pessimistic factor.
No comments:
Post a Comment